The observation that the differential clinical significance of HA and HYAL1 (Hyaluronidase 1), the correlation of Hyaluronidase enzyme in prostate tumor, its application for detecting intermediate and in high-grade bladder cancer [37] indicated the possible down regulation of HA in poorly differentiated tumors. This evidence concerns the gene HYAL1 and urinary bladder cancer.